Processa Pharmaceuticals Inc.

PCSA | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.90

+$0.06 (+3.26%)

Sep 22, 2026, 11:39 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.26%

(1D)

Rating

Updated: Aug 12, 2026

19.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $5.26M

1D Range

1.85 1.91

52W Range

1.67 14.25

Valuation (TTM)

PE -0.33

PB -16.05

EV/EBITDA -0.48

Valuation (NTM)

Forward PE N/A

Forward PEG 0.03

Price Target $225

Cash Flow

FCF Yield -225.2%

SBC Adj. FCF Yield -232.8%

SBC Impact -3.4%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 94.7% | 54.9%

FCF 3Y | 5Y -10.4% | -7.4%

Returns

ROA -649.3%

ROE -394.2%

ROIC 4051.8%

Financial Health

Net Cash

$196.33K

Current Ratio 0.87

Interest Coverage -6,419.41

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Processa Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development stage, committed to identifying and progressing therapeutic agents for patients with critical unmet medical re...

Sector Healthcare

Industry Biotechnology

Employees 12

IPO Date Mar 6, 2014

Website www.processapharmaceuticals.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.